NCI Community Oncology Research Program Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic... | Best Practice, Laboratory Biomarker Analysis, Supportive Care | NCT03253848 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive... | Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring | NCT03723928 | Southwest Oncology Group | Recruiting |
| S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast... | Carvedilol, Laboratory Biomarker Analysis, Patient Observation | NCT03418961 | Southwest Oncology Group | Recruiting |
| S0820, Adenoma and Second Primary Prevention Trial | Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo | NCT01349881 | Southwest Oncology Group | Recruiting |
| Reproductive Health Program in Patients With Cancer | Standard practice related to reproductive heath, Training modules, algorithm, referral development | NCT01806129 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention | NCT05008848 | Alliance for Clinical Trials in Oncology | Recruiting |
| Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who... | Laboratory Biomarker Analysis, Trastuzumab, Whole Breast Irradiation | NCT00769379 | National Cancer Institute (NCI) | Active, not recruiting |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection... | Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate | NCT03887702 | Southwest Oncology Group | Active, not recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... | Endocrine therapy interruption | NCT02308085 | ETOP IBCSG Partners Foundation | Active, not recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... | Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment | NCT03633331 | Alliance for Clinical Trials in Oncology | Active, not recruiting |